Optimind Pharma Corp. (CSE: OMND)
Canada
· Delayed Price · Currency is CAD
0.0050
0.00 (0.00%)
Dec 18, 2024, 4:00 PM EST
Optimind Pharma Revenue
Optimind Pharma had revenue of 41.06K CAD in the quarter ending August 31, 2024, with 50.12% growth. This brings the company's revenue in the last twelve months to 111.44K, down -34.88% year-over-year. In the fiscal year ending February 29, 2024, Optimind Pharma had annual revenue of 122.96K, down -27.72%.
Revenue (ttm)
111.44K
Revenue Growth
-34.88%
P/S Ratio
4.80
Revenue / Employee
n/a
Employees
n/a
Market Cap
548.94K
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Feb 29, 2024 | 122.96K | -47.15K | -27.72% |
Feb 28, 2023 | 170.11K | 70.42K | 70.64% |
Feb 28, 2022 | 99.69K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition